Replies to post #26706 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Gaboy stated: "I'm of the opinion until Biocurex has a steady revenue stream, signs another license agreement or gets a positive update from Inverness, the share price will hoover in the current range."

Gaboy, I agree with the above but not that the stock price will hover in the current range. It will continue to drop.

I will also clearly state that if Moro ever gets a significant steady revenue, signs another million dollar licensee, or if Inverness announces they are indeed planning on marketing RECAF, I will cease posting then and there. None of those three things will ever happen for BioCurex.

Gaboy stated: "By Golds definition the announcements of the Abbott and Inverness license agreements were pumps as well."

Not true at all. What I do think is that Moro led both Inverness and Abbott to believe things that were not true.

[Gold Seeker]

Gaboy stated: "If you look at Gold's past post he claimed the following, might I add and posted several times:

1.) Abbott would return their license, which they haven't"

The effect of the amendment is the same and as a result of the agreement, $50,000 due BioCurex at the time was specifically canceled by the agreement.

"2.) Inverness would return their licnese which they haven't"

They have not returned the license but Moro stated in a filing that he did not know how nor when Inverness would pay any royalties. There is a provision in the Inverness license that Moro cannot give a license to anyone for less minimum royalties than Inverness would pay. Moro violated that license when he gave an amended license to Abbott for zero minimum royalties.


"3.) Biocurex would close the doors, which they haven't "

I did not think Moro could get any more funding but he did. It surprised me but even those guys have lost money now.


"4.) Smithline would receive all rights to Recaf which they haven't"

Smithline has indeed been officially assigned the patents by the USPTB. He owns them until he is totally paid.


"5.) Gold is already telling people Dr. Moro will blow through the money raised during the public offering even though they have enough money to last 3 years"

If Moro spends money as stated in the filings to develop the POC test, etc., he would be out of money in a year. You also claim the next news will be another million dollar licensee as stated by Burger. That just wont happen. No company like Roche is stupid enough to sign a license when Abbott folded their tent with RECAF.

[Gold Seeker]

Gaboy, you stated that Moro had money for three years.

As of March 31, Moro had 3.1 million in cash. His cash operating expensed can be about $700,000 per year. When you add His and Burgers salary, you get $1,000,000 per year and that is paying for all services in stock. As you can see below, Moro still continues to issue stock for services. Moro has to make the money last and he knows it.

b) In February 2010, the Company issued 800,000 shares of common stock
with a fair value of $56,000 for consulting services.

c) In February 2010, the Company issued 200,000 shares of common stock to
a vendor to settle $14,000 of services owed.

d) In February 2010, a total of 920,000 stock options were exercised at
$0.001 per share.

e) In February 2010, the Company issued 347,727 shares of common stock
pursuant to the cashless exercise of 1,275,000 warrants by a note
holder. This exercise was based on the cashless exercise provision of
the stock purchase warrant

f) In February 2010, the Company issued 357,143 shares of common stock
with a fair value of $25,000 for legal services provided.

On April 4, 2006, the Company entered into a consulting agreement with a
term of nine months for consideration of 75,000 common shares. As of March
31, 2010, the Company has issued 37,500 common shares and 37,500 common
shares are still owed to the consultant.

b) On April 10, 2006, the Company entered into a consulting agreement with a
term of one year for consideration of 75,000 common shares. As of March
31, 2010, the Company has issued 37,500 common shares and 37,500 common
shares are still owed to the consultant.

13. SUBSEQUENT EVENT

On April 20, 2010, the Company issued 284,000 shares of common stock pursuant
to stock options exercised at $0.001 per share for common shares
subscriptions totaling $284 received in March 2010.

[Gold Seeker]

Gaboy, from the latest filing, " As at March 31, 2010, the
Company has a working capital of $2,133,823"

You can see from my previous post that spending no cash beyondy the minimal operating expenses of the company, Moro can continue to issue press releases and go to the ISOBM for two years if and only if he does not spend any of his cash on the POC development, trials or any product submissions to the FDA. If Moro attempts to move forward on marginal programs, the money will go away in a hurry.